Literature DB >> 10205276

Evidence for effective suppression of recombination in the chromosome 17q21 segment spanning RNU2-BRCA1.

X Liu1, D F Barker.   

Abstract

Characterization of associations between polymorphic sites located throughout the approximately 200-400-kb variable-length region spanning RNU2-BRCA1 reveals nearly complete linkage disequilibrium. This segment spans the RNU2 array, which includes 6-30 tandem copies of the U2 snRNA gene, and an adjacent region containing NBR1, the LBRCA1 pseudogene, NBR2, and BRCA1 in a tandemly duplicated structure. A series of biallelic polymorphisms define two common haplotypes that do not vary significantly, in structure or frequency, between populations of primarily European (n=275) or Asian (n=34) ancestry. Lower-frequency variants occurring at distantly located sites within this region also show very strong associations. The rarer haplotype classes appear to be distinguished by mutational alteration and are not recombination products of the two major classes. The two major haplotypes also exhibit significantly different allele-length distributions for local simple tandem-repeat markers. The conservation of extensive distinct chromosomal haplotypes during a long period of human population expansion and divergence indicates that selective forces or specific chromosomal mechanisms result in effective recombination suppression. The extreme degree of long-range linkage disequilibrium at this locus may be exceeded only by that reported for the human MHC locus, where allele-specific functional interactions are believed to be significant. These findings have implications for the estimation of the time of origin of BRCA1 mutations having a founder effect, the interpretation of the significance of rare allelic variants, and the study of the origins of modern populations.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10205276      PMCID: PMC1377881          DOI: 10.1086/302358

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  73 in total

1.  The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women.

Authors:  D Abeliovich; L Kaduri; I Lerer; N Weinberg; G Amir; M Sagi; J Zlotogora; N Heching; T Peretz
Journal:  Am J Hum Genet       Date:  1997-03       Impact factor: 11.025

2.  Heterogeneity in rates of recombination in the 6-Mb region telomeric to the human major histocompatibility complex.

Authors:  L Malfroy; M P Roth; M Carrington; N Borot; A Volz; A Ziegler; H Coppin
Journal:  Genomics       Date:  1997-07-15       Impact factor: 5.736

3.  Concerted evolution of the tandemly repeated genes encoding human U2 snRNA (the RNU2 locus) involves rapid intrachromosomal homogenization and rare interchromosomal gene conversion.

Authors:  D Liao; T Pavelitz; J R Kidd; K K Kidd; A M Weiner
Journal:  EMBO J       Date:  1997-02-03       Impact factor: 11.598

4.  X chromosome map at 75-kb STS resolution, revealing extremes of recombination and GC content.

Authors:  R Nagaraja; S MacMillan; J Kere; C Jones; S Griffin; M Schmatz; J Terrell; M Shomaker; C Jermak; C Hott; M Masisi; S Mumm; A Srivastava; G Pilia; T Featherstone; R Mazzarella; S Kesterson; B McCauley; B Railey; F Burough; V Nowotny; M D'Urso; D States; B Brownstein; D Schlessinger
Journal:  Genome Res       Date:  1997-03       Impact factor: 9.043

5.  Archaic African and Asian lineages in the genetic ancestry of modern humans.

Authors:  R M Harding; S M Fullerton; R C Griffiths; J Bond; M J Cox; J A Schneider; D S Moulin; J B Clegg
Journal:  Am J Hum Genet       Date:  1997-04       Impact factor: 11.025

6.  Phylogenetic estimation in humans and neck riddles.

Authors:  R L Cann
Journal:  Am J Hum Genet       Date:  1997-04       Impact factor: 11.025

7.  Isolation and characterisation of the NBR2 gene which lies head to head with the human BRCA1 gene.

Authors:  C F Xu; M A Brown; H Nicolai; J A Chambers; B L Griffiths; E Solomon
Journal:  Hum Mol Genet       Date:  1997-07       Impact factor: 6.150

8.  Common BRCA1 variants and susceptibility to breast and ovarian cancer in the general population.

Authors:  A M Dunning; M Chiano; N R Smith; J Dearden; M Gore; S Oakes; C Wilson; M Stratton; J Peto; D Easton; D Clayton; B A Ponder
Journal:  Hum Mol Genet       Date:  1997-02       Impact factor: 6.150

9.  Human BRCA1 inhibits growth in yeast: potential use in diagnostic testing.

Authors:  J S Humphrey; A Salim; M R Erdos; F S Collins; L C Brody; R D Klausner
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-27       Impact factor: 11.205

10.  Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families.

Authors:  E Levy-Lahad; R Catane; S Eisenberg; B Kaufman; G Hornreich; E Lishinsky; M Shohat; B L Weber; U Beller; A Lahad; D Halle
Journal:  Am J Hum Genet       Date:  1997-05       Impact factor: 11.025

View more
  12 in total

1.  Haplotype and linkage disequilibrium architecture for human cancer-associated genes.

Authors:  Penelope E Bonnen; Peggy J Wang; Marek Kimmel; Ranajit Chakraborty; David L Nelson
Journal:  Genome Res       Date:  2002-12       Impact factor: 9.043

2.  Haplotype analysis of the 185delAG BRCA1 mutation in ethnically diverse populations.

Authors:  Yael Laitman; Bing-Jian Feng; Itay M Zamir; Jeffrey N Weitzel; Paul Duncan; Danielle Port; Eswary Thirthagiri; Soo-Hwang Teo; Gareth Evans; Ayse Latif; William G Newman; Ruth Gershoni-Baruch; Jamal Zidan; Shani Shimon-Paluch; David Goldgar; Eitan Friedman
Journal:  Eur J Hum Genet       Date:  2012-07-04       Impact factor: 4.246

3.  On the origin and diffusion of BRCA1 c.5266dupC (5382insC) in European populations.

Authors:  Nancy Hamel; Bing-Jian Feng; Lenka Foretova; Dominique Stoppa-Lyonnet; Steven A Narod; Evgeny Imyanitov; Olga Sinilnikova; Laima Tihomirova; Jan Lubinski; Jacek Gronwald; Bohdan Gorski; Thomas v O Hansen; Finn C Nielsen; Mads Thomassen; Drakoulis Yannoukakos; Irene Konstantopoulou; Vladimir Zajac; Sona Ciernikova; Fergus J Couch; Celia M T Greenwood; David E Goldgar; William D Foulkes
Journal:  Eur J Hum Genet       Date:  2010-12-01       Impact factor: 4.246

4.  Molecular and genealogical characterization of the R1443X BRCA1 mutation in high-risk French-Canadian breast/ovarian cancer families.

Authors:  Hélène Vézina; Francine Durocher; Martine Dumont; Louis Houde; Csilla Szabo; Martine Tranchant; Jocelyne Chiquette; Marie Plante; Rachel Laframboise; Jean Lépine; Heli Nevanlinna; Dominique Stoppa-Lyonnet; David Goldgar; Peter Bridge; Jacques Simard
Journal:  Hum Genet       Date:  2005-05-10       Impact factor: 4.132

5.  Lack of germ-line mutations at the specific BRCA1-IRIS coding sequence in 114 Spanish high-risk breast/ovarian families.

Authors:  Miguel de la Hoya; Juan Manuel Fernández; Ana Sánchez de Abajo; Alicia Tosar; Eduardo Díaz-Rubio; Trinidad Caldés
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

6.  Mutation analysis of BRCA1 and BRCA2 genes in Iranian high risk breast cancer families.

Authors:  Andrea Pietschmann; Parvin Mehdipour; Parvin Mehdipour; Morteza Atri; Wera Hofmann; S Said Hosseini-Asl; Siegfried Scherneck; Stefan Mundlos; Hartmut Peters
Journal:  J Cancer Res Clin Oncol       Date:  2005-05-26       Impact factor: 4.553

7.  Estimation of the RNU2 macrosatellite mutation rate by BRCA1 mutation tracing.

Authors:  Chloé Tessereau; Yann Lesecque; Nastasia Monnet; Monique Buisson; Laure Barjhoux; Mélanie Léoné; Bingjian Feng; David E Goldgar; Olga M Sinilnikova; Sylvain Mousset; Laurent Duret; Sylvie Mazoyer
Journal:  Nucleic Acids Res       Date:  2014-07-17       Impact factor: 16.971

8.  Common variation in the BRCA1 gene and prostate cancer risk.

Authors:  Julie A Douglas; Albert M Levin; Kimberly A Zuhlke; Anna M Ray; Gregory R Johnson; Ethan M Lange; David P Wood; Kathleen A Cooney
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-06-21       Impact factor: 4.254

9.  The frequent BRCA1 mutation 1135insA has multiple origins: a haplotype study in different populations.

Authors:  Teresa M Rudkin; Nancy Hamel; Maria Galvez; Frans Hogervorst; Johan J P Gille; Pål Møller; Jaran Apold; William D Foulkes
Journal:  BMC Med Genet       Date:  2006-03-01       Impact factor: 2.103

10.  The BRCA1 Ashkenazi founder mutations occur on common haplotypes and are not highly correlated with anonymous single nucleotide polymorphisms likely to be used in genome-wide case-control association studies.

Authors:  Lutécia H Mateus Pereira; Marbin A Pineda; William H Rowe; Libia R Fonseca; Mark H Greene; Kenneth Offit; Nathan A Ellis; Jinghui Zhang; Andrew Collins; Jeffery P Struewing
Journal:  BMC Genet       Date:  2007-10-04       Impact factor: 2.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.